84 related articles for article (PubMed ID: 9325184)
1. Enterocytic differentiation correlates with changes in the fine structure and sulfation of perlecan in HT29 human colon carcinoma cells.
Molist A; Romarís M; Villena J; Bassols A
Biochem Biophys Res Commun; 1997 Sep; 238(3):874-9. PubMed ID: 9325184
[TBL] [Abstract][Full Text] [Related]
2. Changes in glycosaminoglycan structure and composition of the main heparan sulphate proteoglycan from human colon carcinoma cells (perlecan) during cell differentiation.
Molist A; Romarís M; Lindahl U; Villena J; Touab M; Bassols A
Eur J Biochem; 1998 Jun; 254(2):371-7. PubMed ID: 9660193
[TBL] [Abstract][Full Text] [Related]
3. Presence of unsulfated heparan chains on the heparan sulfate proteoglycan of human colon carcinoma cells. Implications for heparan sulfate proteoglycan biosynthesis.
Iozzo RV
J Biol Chem; 1989 Feb; 264(5):2690-9. PubMed ID: 2521630
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences.
Tumova S; Woods A; Couchman JR
J Biol Chem; 2000 Mar; 275(13):9410-7. PubMed ID: 10734086
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro.
Jayson GC; Lyon M; Paraskeva C; Turnbull JE; Deakin JA; Gallagher JT
J Biol Chem; 1998 Jan; 273(1):51-7. PubMed ID: 9417046
[TBL] [Abstract][Full Text] [Related]
7. Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains.
Hovingh P; Piepkorn M; Linker A
Eur J Biochem; 1993 Feb; 211(3):771-9. PubMed ID: 8436134
[TBL] [Abstract][Full Text] [Related]
8. Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells.
Salmivirta M; Safaiyan F; Prydz K; Andresen MS; Aryan M; Kolset SO
Glycobiology; 1998 Oct; 8(10):1029-36. PubMed ID: 9719684
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of glycosaminoglycans in the human colonic tumor cell line Caco-2: structural changes occurring with the morphological differentiation of the cells.
Levy P; Robert A; Picard J
Biol Cell; 1988; 62(3):255-64. PubMed ID: 3401619
[TBL] [Abstract][Full Text] [Related]
10. Modulation of heparan sulfate biosynthesis. Effects of 6-diazo-5-oxo-L-norleucine and low glutamine on the synthesis of heparan sulfate proteoglycan by human colon carcinoma cells.
Iozzo RV; Clark CC
J Biol Chem; 1987 Aug; 262(23):11188-99. PubMed ID: 2956263
[TBL] [Abstract][Full Text] [Related]
11. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
12. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
13. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials.
Nakanishi H; Oguri K; Yoshida K; Itano N; Takenaga K; Kazama T; Yoshida A; Okayama M
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):215-24. PubMed ID: 1445266
[TBL] [Abstract][Full Text] [Related]
14. Membrane-intercalated proteoglycan of a stroma-inducing clone from Lewis lung carcinoma binds to fibronectin via its heparan sulfate chains.
Itano N; Oguri K; Nakanishi H; Okayama M
J Biochem; 1993 Dec; 114(6):862-73. PubMed ID: 8138544
[TBL] [Abstract][Full Text] [Related]
15. Turnover of heparan sulfate proteoglycan in human colon carcinoma cells. A quantitative biochemical and autoradiographic study.
Iozzo RV
J Biol Chem; 1987 Feb; 262(4):1888-900. PubMed ID: 2948961
[TBL] [Abstract][Full Text] [Related]
16. Sulphated and undersulphated heparan sulphate proteoglycans in a Chinese hamster ovary cell mutant defective in N-sulphotransferase.
Bame KJ; Zhang L; David G; Esko JD
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):81-7. PubMed ID: 7945269
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a small hydrophobic domain in the core protein of the heparan sulfate proteoglycan from human colon carcinoma cells.
Iozzo RV; Ketterer CL; Slaymaker DJ
FEBS Lett; 1986 Oct; 206(2):304-8. PubMed ID: 2944764
[TBL] [Abstract][Full Text] [Related]
18. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
Klein DJ; Oegema TR; Brown DM
Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface.
Iozzo RV
J Cell Biol; 1984 Aug; 99(2):403-17. PubMed ID: 6235235
[TBL] [Abstract][Full Text] [Related]
20. Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells.
Safaiyan F; Lindahl U; Salmivirta M
Eur J Biochem; 1998 Mar; 252(3):576-82. PubMed ID: 9546676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
